Various polyspecific autoantibodies have been described in the sera of
patients with IgA nephropathy, including anti-IgG, anti-IgA, antigala
ctosyl, antifibronectin and antimesangial antibodies. We and other aut
hors have demonstrated the presence of antivascular endothelial cell (
VEC) antibodies, in up to 32% of patients with IgA nephropathy. These
antibodies were directed against molecules on the endothelial cell sur
face. Some of these antibodies were directed against HLA class I antig
ens; the majority, however, were reactive against antigens present on
unstimulated endothelial cells, as prior stimulation of the cells with
interferon-gamma or interleukin 1 did not result in an increase in an
ti-VEC activity of the sera. The clinical significance of these anti-V
EC antibodies in IgA nephropathy is unknown. A significant correlation
was demonstrated between these antibodies and the presence of heavy p
roteinuria, A significant association was also shown between the prese
nce of these antibodies and the histopathologic markers of activity su
ch as crescents and focal and segmental necrotizing lesions, as well a
s immunoglobulin and C3 deposition in the vessel walls.